Literature DB >> 19923111

Diagnosis and management of the limb girdle muscular dystrophies.

Kate Bushby1.   

Abstract

Making the diagnosis of a particular type of limb girdle muscular dystrophy (LGMD) can appear challenging. In fact, various clues from the way the patient presents, and the results of simple investigations such as creatine kinase levels, can be extremely helpful in sorting out the various disease entities within this group of patients. The results of more specialised testing of the muscle biopsy and DNA sequencing offer the prospect of a clear answer in around 75% of cases. As more is understood about the clinical features of the different types of LGMD, targeted management is increasingly possible, especially focusing on those patients at high risk of cardiac and respiratory complications.

Entities:  

Mesh:

Year:  2009        PMID: 19923111     DOI: 10.1136/jnnp.2009.193938

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  25 in total

1.  A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.

Authors:  Peter R Serafini; Michael J Feyder; Rylie M Hightower; Daniela Garcia-Perez; Natássia M Vieira; Angela Lek; Devin E Gibbs; Omar Moukha-Chafiq; Corinne E Augelli-Szafran; Genri Kawahara; Jeffrey J Widrick; Louis M Kunkel; Matthew S Alexander
Journal:  JCI Insight       Date:  2018-09-20

2.  [Muscular dystrophy due to mutations in anoctamin 5: clinical and molecular genetic findings].

Authors:  M Deschauer; P R Joshi; D Gläser; F Hanisch; G Stoltenburg; S Zierz
Journal:  Nervenarzt       Date:  2011-12       Impact factor: 1.214

3.  Normal vaginal delivery in a patient with autosomal recessive limb-girdle muscular dystrophy.

Authors:  Carin Black; Joanne Said
Journal:  Obstet Med       Date:  2010-06-03

4.  Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular dystrophy and myopathy with movement disorder and intellectual disability.

Authors:  Nina Bögershausen; Nassim Shahrzad; Jessica X Chong; Jürgen-Christoph von Kleist-Retzow; Daniela Stanga; Yun Li; Francois P Bernier; Catrina M Loucks; Radu Wirth; Eric G Puffenberger; Robert A Hegele; Julia Schreml; Gabriel Lapointe; Katharina Keupp; Christopher L Brett; Rebecca Anderson; Andreas Hahn; A Micheil Innes; Oksana Suchowersky; Marilyn B Mets; Gudrun Nürnberg; D Ross McLeod; Holger Thiele; Darrel Waggoner; Janine Altmüller; Kym M Boycott; Benedikt Schoser; Peter Nürnberg; Carole Ober; Raoul Heller; Jillian S Parboosingh; Bernd Wollnik; Michael Sacher; Ryan E Lamont
Journal:  Am J Hum Genet       Date:  2013-07-03       Impact factor: 11.025

5.  Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin 3 gene.

Authors:  Maria J Melià; Akatsuki Kubota; Saida Ortolano; Juan J Vílchez; Josep Gámez; Kurenai Tanji; Eduardo Bonilla; Lluís Palenzuela; Israel Fernández-Cadenas; Anna Pristoupilová; Elena García-Arumí; Antoni L Andreu; Carmen Navarro; Michio Hirano; Ramon Martí
Journal:  Brain       Date:  2013-03-29       Impact factor: 13.501

6.  Variants in SNAP25 are targets of natural selection and influence verbal performances in women.

Authors:  Rachele Cagliani; Stefania Riva; Cecilia Marino; Matteo Fumagalli; Maria Grazia D'Angelo; Valentina Riva; Giacomo P Comi; Uberto Pozzoli; Diego Forni; Mario Cáceres; Nereo Bresolin; Mario Clerici; Manuela Sironi
Journal:  Cell Mol Life Sci       Date:  2011-12-23       Impact factor: 9.261

7.  Diagnostic delay in patients with FKRP-related muscular dystrophy.

Authors:  Lauren N Coffey; Carrie M Stephan; M B Zimmerman; Chyan K Decker; Katherine D Mathews
Journal:  Neuromuscul Disord       Date:  2021-09-06       Impact factor: 4.296

8.  Office based muscle biopsy using Vacora vacuum assisted biopsy system.

Authors:  S N Akarolo-Anthony; T O Ogundiran; C Nkwodimmah; A Famooto; A S Famooto; J Adediji; C N Rotimi; W Balogun; J Adeleye; C A Adebamowo
Journal:  Afr J Med Med Sci       Date:  2012-09

9.  Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity.

Authors:  Antoine de Morrée; Paul J Hensbergen; Herman H H B M van Haagen; Irina Dragan; André M Deelder; Peter A C 't Hoen; Rune R Frants; Silvère M van der Maarel
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

10.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.